2001
CTOS Annual Meeting Posters— Radiation
Oncology
A COMPARISON OF
LOWER EXTREMITY FUNCTIONAL OUTCOME FOLLOWING LIMB PERFUSION, PRE-
OR POST-OPERATIVE RADIOTHERAPY FOR SOFT TISSUE SARCOMA
Peter Hohenberger1, Jay Wunder2, Anja
Herrmann1, Anthony Griffin2, Robert
Bell2, Brian O'Sullivan3, Charles
Catton3, Aileen Davis4
1Robert-Roessle Hospital and Tumor Institute at the
Max-Debruck Center for Molecular Medicine, 2Mount
Sinai Hospital, 3Princess Margaret Hospital, 4Toronto
Rehabilitation Institute
OBJECTIVE: The disability outcomes of patients with lower extremity
soft tissue sarcoma (STS) treated with limb sparing surgery and adjuvant
therapy of intra-arterial limb perfusion (ILP) or preoperative external
beam radiotherapy (preop) or post-operative external beam radiotherapy
(postop) were compared.
METHODS: 29 patients in each of the three treatment groups
were matched for age, anatomical tumour site, tumour size and months
of functional follow-up. Baseline sample characteristics (age, gender,
primary vs. recurrent tumour) and variables known to impact on functional
outcome (motor nerve sacrifice, bone resection, complications, vascular
reconstruction) were compared to ensure group similarity. The primary
outcome, the Toronto Extremity Salvage Score (TESS), was evaluated
among the three groups using a paired t-test and then regression
analysis.
RESULTS: There were no significant differences among the
groups on any of age (group mean range 44 to 47), tumour size, anatomical
location, months of functional follow-up (group mean range 21 to
23 mos). Although not significantly different, 11 of the ILP group
presented with recurrent tumour as compared to 3 in the preop and
2 in the postop groups. There were no statistically significant
differences in the number of cases with bone, major motor nerve,
or vessel resection or in wound complications in the three groups.
The ILP group had a lower TESS score than the postop rads group
(p=0.005); TESS means of 80.8 vs. 91.5 vs. 85.6 for the ILP, preop
and postop groups respectively. In a model evaluating gender and
treatment group, gender was a significant predictor of the TESS
(men mean of 87.1 vs women mean of 75.7, p=0.005) but treatment
group was not significant (p=0.144). Use of pain medication was
the same in all groups (6, 6 and 5 cases) but 5 in the ILP group
used an ambulatory aids as compared to 2 and 1 in the preop and
postop rads groups. At last follow-up 4 ILP patients and 1 postop
case had developed local recurrence. 9 of the ILP, 6 of the preop
and 4 of the postop group had metastatic disease.
CONCLUSION: STS patients undergoing ILP, preop or postop
radiotherapy report relatively high levels of function with the
least disability reported in the preop radiotherapy group. In these
data, women have lower scores than men, particularly in the ILP
treatment group.
|